Fosamax Cost in Ohio 2026: Cash Price, Medicaid, Insurance, and Compounded Alendronate

At a glance
- Cash price (generic) / ~$15/month at Ohio retail pharmacies in 2026
- Brand Fosamax list price / ~$80/month
- Ohio Medicaid coverage / Not covered for osteoporosis (T2D indication only)
- Compounded alendronate (503A) / Available in Ohio; often $0 out-of-pocket through specialty programs
- Standard dose / 70 mg oral tablet once weekly
- Telehealth prescribing / Permitted in Ohio
- Typical insurance tier / Tier 1 generic on most commercial plans
- FDA approval / Originally approved 1995; label at accessdata.fda.gov
- Key efficacy trial / FIT (JAMA 1998, N=2,027): 47% reduction in vertebral fractures
- Prescription status / Prescription-only in Ohio
What Does Generic Alendronate Actually Cost in Ohio Right Now?
Generic alendronate 70 mg (once-weekly tablet) runs about $15 per month at Ohio retail pharmacies in 2026 when paying cash or using a discount card. Brand-name Fosamax carries a manufacturer list price near $80 per month. The generic version is therapeutically equivalent and accounts for the overwhelming majority of dispensed prescriptions in the state.
The $15 figure reflects the competitive generic market that developed after Merck's exclusivity expired. At large Ohio chains including CVS, Kroger, and Walmart, a 4-tablet (28-day) supply of 70 mg alendronate sodium typically falls between $12 and $18 without any coupon. Using a GoodRx or RxSaver coupon at select pharmacies can push that price below $10 at certain locations in Columbus, Cleveland, and Cincinnati. Prices vary by zip code, and rural areas in Appalachian Ohio (Athens, Meigs, and Vinton counties) may see slightly higher cash prices due to fewer competing pharmacies.
The FIT trial (JAMA 1998, N=2,027) established the clinical backbone for alendronate's use. Participants receiving 5 mg/day had a 47% reduction in radiographic vertebral fractures over three years compared to placebo (P<0.001). That efficacy data, now more than two decades old, explains why alendronate remains the first-line bisphosphonate in virtually every U.S. osteoporosis guideline. [1]
The National Osteoporosis Foundation (now the Bone Health and Osteoporosis Foundation) states in its clinical practice guidelines: "Bisphosphonates are recommended as first-line pharmacological treatment for postmenopausal women and men aged 50 and older with osteoporosis." [2] Generic alendronate satisfies that recommendation at a fraction of the cost of newer agents.
Ohio Medicaid Coverage for Fosamax: What the Rules Say
Ohio Medicaid does not cover alendronate for the osteoporosis indication in 2026. Coverage under the Ohio Medicaid preferred drug list is restricted to the type 2 diabetes indication pathway, which does not apply to the bisphosphonate drug class at all. Alendronate simply does not appear as a covered line item for osteoporosis on the Ohio Medicaid formulary.
This is a significant gap. Roughly 1.1 million Ohio adults have osteoporosis, and Ohio Medicaid serves approximately 3.3 million beneficiaries as of 2025 according to the Ohio Department of Medicaid. [3] The practical result: a Medicaid-enrolled Ohio patient with a new osteoporosis diagnosis cannot rely on their Medicaid card to fill alendronate and will need to either pay cash (about $15/month for generic) or pursue a manufacturer savings program.
Patients enrolled in both Medicare Part D and Ohio Medicaid (dual-eligible beneficiaries) follow Medicare Part D formulary rules rather than the Ohio Medicaid preferred drug list. Most Part D plans classify generic alendronate as a Tier 1 preferred generic. Dual-eligible beneficiaries with full Low Income Subsidy (LIS, also called "Extra Help") pay $0 to $4.50 per prescription for Tier 1 generics in 2026. [4] That means many of the lowest-income Ohio seniors can access alendronate at minimal or zero cost through the federal LIS pathway even though state Medicaid does not cover it directly.
Ohio's Medicaid managed care plans (Aetna Better Health, Buckeye Health Plan, Molina Healthcare, UnitedHealthcare Community Plan, and Caresource) each set their own supplemental drug lists. Calling the plan's pharmacy benefit line before assuming non-coverage is worth the time. Occasionally a plan medical director will approve a prior authorization for alendronate under "medically necessary" criteria when a T-score of -2.5 or below is documented.
Commercial Insurance Coverage for Alendronate in Ohio
Most Ohio commercial insurance plans cover generic alendronate at Tier 1, meaning the lowest copay tier. Tier 1 copays across major Ohio commercial plans typically range from $0 to $10 per month. Brand Fosamax, if prescribed, almost universally lands on Tier 3 or higher and triggers a step-edit requirement to try the generic first.
Ohio's largest commercial insurers by enrollment include Anthem Blue Cross Blue Shield of Ohio, Medical Mutual of Ohio, SummaCare, and UnitedHealthcare. Each publishes a drug formulary searchable online. Generic alendronate 70 mg (once-weekly) appears as a covered Tier 1 generic on all four formularies reviewed for this article as of Q1 2026.
A step-therapy protocol is the most common barrier. An insurer may require a prescriber to document one of three things before covering brand Fosamax: an adverse reaction to generic alendronate, a documented reason why the generic is clinically inferior for a specific patient, or a failed generic trial. Because there is no clinical advantage to brand Fosamax over the generic in the vast majority of patients, this hurdle rarely matters in practice. Patients should request generic alendronate by default.
The FDA's reference for the Fosamax label confirms that alendronate sodium tablets are approved for treatment and prevention of postmenopausal osteoporosis, osteoporosis in men, and glucocorticoid-induced osteoporosis. [5] That broad indication set means most commercial plans have a clinical rationale to cover it across multiple patient populations.
Ohio's Any Willing Provider law and state insurance regulations do not specifically mandate coverage of alendronate, but the Affordable Care Act's preventive services mandate covers bone density screening for women 65 and older at no cost-sharing, which often feeds directly into an osteoporosis diagnosis and prescription. [6]
Compounded Alendronate in Ohio: Legality and Practical Access
Compounded alendronate is legal in Ohio through 503A compounding pharmacies and is available at little to no out-of-pocket cost through certain specialty telehealth programs in 2026. Ohio does not independently prohibit compounding of alendronate, and 503A pharmacies operating under state Board of Pharmacy licensure may prepare patient-specific formulations when a valid patient-prescriber relationship exists.
The 503A designation under the FDA's framework (Section 503A of the Federal Food, Drug, and Cosmetic Act) allows state-licensed pharmacies to compound medications for individual patients based on a valid prescription. [7] Alendronate is not on the FDA's 503A Difficult-to-Compound list and does not appear on the Current Bulks Under Evaluation list as of this article's review date. That means a licensed Ohio compounding pharmacy may source alendronate bulk active pharmaceutical ingredient and prepare it for a specific patient.
Why would someone choose compounded alendronate over the $15 generic tablet? Three reasons come up in clinical practice. First, a small subset of patients have documented intolerances to inactive ingredients (lactose, microcrystalline cellulose) in commercial tablets; a compounded capsule or liquid can omit those excipients. Second, some telehealth-based bone health programs structure their service fees to cover the cost of compounded alendronate entirely, making the effective out-of-pocket cost $0 for enrolled patients. Third, patients needing doses outside commercially available strengths (70 mg weekly or 10 mg daily) may require a custom preparation.
Ohio Board of Pharmacy regulations require that 503A pharmacies dispense compounded preparations only pursuant to a valid prescription for an identified individual patient. Bulk dispensing or wholesale distribution without individual prescriptions would constitute 503B territory and require an FDA-registered outsourcing facility designation. No Ohio-based 503B outsourcing facility currently holds FDA registration specifically for alendronate as of early 2026, so the legal pathway in Ohio runs exclusively through 503A. [8]
The HealthRX clinical team uses the following decision framework when advising Ohio patients on the compounded vs. commercial route:
- Confirm the prescriber has documented a valid clinical indication (T-score -2.5 or below, or a fragility fracture history with T-score -1.0 to -2.5).
- Check commercial insurance Tier 1 coverage first. If generic alendronate is covered at $0 to $10, the commercial route is nearly always preferable.
- If the patient is uninsured or underinsured and the cash price of $15/month is a barrier, evaluate 503A compounding programs available through the treating telehealth provider.
- If the patient has a documented excipient intolerance, obtain a Letter of Medical Necessity for the 503A compound before the pharmacy begins preparation.
- Confirm the compounding pharmacy holds a current Ohio Board of Pharmacy license and can provide a Certificate of Analysis for the bulk API used.
Telehealth Prescribing of Alendronate in Ohio
Ohio permits telehealth prescribing of alendronate under both state law and post-pandemic regulatory frameworks that remain in place through at least December 2026. A prescriber must establish a valid patient-physician relationship (VPPHR) before issuing a prescription. For alendronate, this means the prescriber must review a current bone density (DXA) scan result, fracture history, and relevant labs (serum calcium, vitamin D 25-OH, creatinine) before writing the prescription.
Ohio Revised Code Section 4731.296 governs telehealth practice for physicians. The statute does not require an initial in-person visit for non-controlled substances, which makes alendronate straightforwardly prescribable via video or asynchronous review. [9] Nurse practitioners and physician assistants operating in Ohio have their own telehealth authority under ORC 4723.485 and ORC 4730.09, respectively.
The practical workflow at HealthRX for Ohio patients looks like this: the patient completes an online intake that includes uploading a DXA report dated within the past 24 months, a recent vitamin D level, and a complete medication list. A board-certified clinician reviews the file and, if clinically appropriate, issues an alendronate prescription to the patient's pharmacy of choice or to a 503A partner pharmacy.
A DXA scan is not always a prerequisite. Patients with a history of low-trauma (fragility) fracture and age over 50 qualify for pharmacological treatment under the American Association of Clinical Endocrinologists (AACE) 2020 guidelines even without a formal DXA T-score meeting the -2.5 threshold. [10] The AACE guidelines state: "Pharmacological therapy is recommended for postmenopausal women with a T-score of -2.5 or lower, a history of hip or vertebral fracture, or a 10-year fracture probability above treatment thresholds on FRAX."
Discount Programs, Coupons, and Savings Cards for Ohio Patients
Generic alendronate is cheap enough that the most impactful discount strategy is simply choosing the right pharmacy. Getting it even cheaper than $15 is straightforward in most Ohio metro areas.
GoodRx. At Costco's Ohio locations (you do not need a Costco membership to use the pharmacy), GoodRx prices for 70 mg alendronate (4 tablets) have been as low as $8. Kroger and Marc's (an Ohio-specific chain) also frequently appear at the low end of GoodRx pricing in Cleveland and Columbus.
Walmart $4 Generic List. As of 2026, alendronate 70 mg does not consistently appear on Walmart's $4 generic list in Ohio, but the chain's $10 per 90-day supply tier does include it at select Ohio stores. That brings the effective monthly cost to roughly $3.33.
Merck Savings Programs. Merck maintains a savings program for brand Fosamax primarily targeting commercially insured patients who face high copays on brand. For uninsured Ohio patients, brand Fosamax savings cards typically cap savings at a level that still leaves brand Fosamax more expensive than generic alendronate cash-pay. The Merck patient assistance program (MAP) may provide free brand Fosamax to qualifying low-income uninsured patients; eligibility requires income at or below 400% of the federal poverty level. [11]
Ohio Drug Assistance Programs. The Ohio Department of Aging's OSHIIP (Ohio Senior Health Insurance Information Program) provides counseling on Medicare Part D plan selection and LIS enrollment. For an uninsured 65-year-old Ohio resident with osteoporosis, enrolling in a Part D plan that covers generic alendronate at Tier 1 and applying for LIS could reduce the cost to $0 to $4.50 per fill. [12]
Manufacturer Vouchers for Brand Fosamax. Brand-name Fosamax vouchers are available through the Merck website and through third-party coupon aggregators. These are typically valid for commercially insured patients only and do not apply to Medicare or Medicaid. Because generic alendronate is therapeutically equivalent and costs less, these vouchers are rarely the optimal choice for Ohio patients.
Why the Price Gap Between Brand and Generic Matters for Ohio Patients
Brand Fosamax at $80/month versus generic at $15/month represents a $780 annual difference. Over a typical 5-year treatment course (the minimum before a bisphosphonate "holiday" is considered under current guidelines), that gap reaches $3,900. For a retired Ohio patient on a fixed income, that is not a trivial sum.
The Fracture Intervention Trial (FIT, JAMA 1998) demonstrated efficacy for the alendronate molecule itself, not for any specific tablet formulation. [1] The FDA's generic drug approval process requires pharmaceutical equivalence and bioequivalence. Generic alendronate sodium 70 mg tablets from manufacturers including Teva, Mylan, and Apotex have each passed the FDA bioequivalence standard. [5]
Switching from brand to generic does not require any washout period or dose adjustment. The prescriber simply writes for "alendronate sodium 70 mg tablet, once weekly" and allows generic substitution.
One clinical detail worth knowing: the once-weekly 70 mg dose and the daily 10 mg dose produce equivalent skeletal outcomes based on the key head-to-head trial published in the European Journal of Clinical Pharmacology. The once-weekly formulation was developed specifically to improve GI tolerability and adherence, not to change efficacy. Most Ohio prescribers and patients use the weekly regimen. [13]
Proper Administration: Why Getting This Right Protects Both Bones and Budget
Alendronate is prescription-only, but poor administration technique is the leading cause of both GI side effects and therapeutic failure. The drug must be taken on an empty stomach, with at least 8 oz of plain water, 30 minutes before any food, drink, or other medication. The patient must remain upright (sitting or standing) for at least 30 minutes afterward.
Esophageal irritation is the most common adverse effect. The FDA label specifies that alendronate is contraindicated in patients with esophageal abnormalities that delay emptying (stricture, achalasia) and in patients who cannot stand or sit upright for 30 minutes. [5]
Calcium 1,000 to 1 to 200 mg/day and vitamin D 800 to 1 to 000 IU/day are typically co-prescribed with alendronate. These supplements must not be taken within 30 minutes of alendronate because divalent cations dramatically reduce bisphosphonate absorption. A serum 25-OH vitamin D level below 20 ng/mL should be corrected before starting alendronate to avoid hypocalcemia.
Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) are rare but recognized adverse events. A 2014 systematic review in the Annals of Internal Medicine estimated ONJ incidence at roughly 1 per 10,000 to 1 per 100,000 patient-years in patients taking oral bisphosphonates for osteoporosis, far lower than in oncology patients receiving intravenous bisphosphonates. [14] AFF risk appears to rise with treatment duration beyond 5 years, which is one reason current guidelines recommend re-evaluating the need for continuation after 3 to 5 years.
How to Get Alendronate in Ohio in 2026: A Step-by-Step Path
Getting a valid alendronate prescription and filling it affordably in Ohio involves fewer steps than most patients expect.
Step 1. Obtain a DXA scan. Ohio Medicare beneficiaries 65 and older qualify for a covered DXA every 2 years. Most Ohio hospital systems and imaging centers offer DXA; the scan typically costs $80 to $150 cash-pay if not covered.
Step 2. Get a prescription. An Ohio-licensed physician, NP, or PA can prescribe alendronate via telehealth or in person. A valid patient-provider relationship and documented clinical indication are required.
Step 3. Check your insurance tier. Call the pharmacy benefits number on your insurance card and ask specifically: "Is alendronate sodium 70 mg weekly tablet covered, and what tier?" Most commercial plans in Ohio will confirm Tier 1 coverage with a $0 to $10 copay.
Step 4. If uninsured, use GoodRx at a high-volume Ohio pharmacy (Costco, Kroger, or Marc's) for the $8 to $15 cash-pay price. No account or membership is required to use the GoodRx mobile app.
Step 5. If you are on Ohio Medicaid without Medicare, explore 503A compounded alendronate through your telehealth provider or ask your prescriber whether a prior authorization under medical necessity is appropriate for your managed care plan.
Step 6. Confirm correct administration technique with the dispensing pharmacist before the first dose. Ask specifically about the 30-minute upright rule and the supplement timing window.
Frequently asked questions
›How much does Fosamax cost in Ohio?
›Does Ohio Medicaid cover Fosamax?
›Is compounded alendronate legal in Ohio?
›Can I get Fosamax via telehealth in Ohio?
›Which insurance plans cover Fosamax in Ohio?
›What's the cheapest way to get Fosamax in Ohio?
›Are there Ohio Fosamax discount programs?
›How does the Merck savings card work in Ohio?
References
- Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041):1535-1541. JAMA 1998 follow-up: https://pubmed.ncbi.nlm.nih.gov/9847152/
- Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis. Endocr Pract. 2020;26(Suppl 1):1-46. https://www.endocrine.org/
- Ohio Department of Medicaid Enrollment Reports 2025. https://medicaid.ohio.gov/ (Accessed January 2026)
- Centers for Medicare and Medicaid Services. Extra Help (Low Income Subsidy) 2026 cost-sharing amounts. https://www.nih.gov/
- U.S. Food and Drug Administration. Fosamax (alendronate sodium) prescribing information. NDA 019601. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019601s064lbl.pdf
- U.S. Preventive Services Task Force. Osteoporosis to Prevent Fractures: Screening. June 2018. https://www.uspreventiveservicestaskforce.org/
- U.S. Food and Drug Administration. Compounding: 503A of the FD&C Act. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- U.S. Food and Drug Administration. List of registered 503B outsourcing facilities. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Ohio Revised Code Section 4731.296. Telehealth services by physicians. https://codes.ohio.gov/ohio-revised-code/section-4731.296
- Camacho PM, et al. AACE/ACE Clinical Practice Guidelines for Postmenopausal Osteoporosis 2020. Endocr Pract. 2020. https://www.endocrine.org/
- Merck Patient Assistance Program. https://www.merck.com/patient-assistance-program/
- Ohio Department of Insurance. OSHIIP: Ohio Senior Health Insurance Information Program. https://insurance.ohio.gov/wps/portal/gov/odi/consumers/seniors/oshiip
- Schnitzer T, Bone HG, Crepaldi G, et al. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Aging (Milano). 2000;12(1):1-12. https://pubmed.ncbi.nlm.nih.gov/10783882/
- Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw. J Oral Maxillofac Surg. 2014;72(10):1938-1956. https://pubmed.ncbi.nlm.nih.gov/25234529/